Latest Breaking News On - Werewolf therapeutics inc - Page 3 : comparemela.com

Werewolf Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

Werewolf Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesEllen lubmanDanielj hicklinJosh rappaportDuring the american association of immunologists meetingExchange commissionScientific communicationsDrug administrationJazz pharmaceuticalsPacific western bankWerewolf therapeutics incCompany contactAmerican association of immunologists meetingCompany or werewolf nasdaqAmerican society for clinical oncologyTherapeutics reports first quarter

Werewolf Therapeutics Announces WTX-124 Clinical Abstract Accepted for Presentation at the 2024 ...

Company to present an update of its ongoingmonotherapy and combinationPhase 1/1b study of WTX-124 in advanced or metastatic solid tumors

United statesJosh rappaportEllen lubmanCompany contactCompany or werewolf nasdaqScientific communicationsExchange commissionWerewolf therapeutics incAmerican society of clinical oncologyClinical oncologyAnnual meetingNon hodgkin lymphomaPrivate securities litigation reform act

Werewolf Therapeutics Announces WTX-124 Clinical Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Werewolf Therapeutics Announces WTX-124 Clinical Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesJosh rappaportEllen lubmanExchange commissionWerewolf therapeutics incAmerican society of clinical oncologyScientific communicationsCompany contactCompany or werewolf nasdaqAbstract acceptedClinical oncologyAnnual meetingNon hodgkin lymphomaPrivate securities litigation reform act

Werewolf Therapeutics Presents First Preclinical Data Highlighting IL-10 INDUKINE Molecules as a Potential Therapy for Inflammatory Bowel Disease (IBD) at AAI Annual Meeting

Werewolf Therapeutics Presents First Preclinical Data Highlighting IL-10 INDUKINE Molecules as a Potential Therapy for Inflammatory Bowel Disease (IBD) at AAI Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDanielj hicklinExchange commissionCrohn colitis foundationCenters for diseaseCompany contactAmanda sellersverge scientific communicationsCompany or werewolf nasdaqCompany formDevelopment of conditionally activeAmerican association of immunologistsWerewolf therapeutics incFirst data demonstrating applicationAmerican associationChief executive officerDisease control

Werewolf Therapeutics (NASDAQ:HOWL) Earns Mkt Outperform Rating from Analysts at JMP Securities

Werewolf Therapeutics (NASDAQ:HOWL) Earns Mkt Outperform Rating from Analysts at JMP Securities
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Cubist systematic strategiesWerewolf therapeutics incFinancial perspectives incWerewolf therapeuticsFree reportGet free reportPerspectives incStreet groupSystematic strategiesTwo sigma investmentsWerewolf therapeutics daily